Table 1 Baseline and perioperative characteristics
Variable | Group E (n = 28) | Group TR (n = 27) | P value |
|---|---|---|---|
Gender | |||
 Male | 10 (35.7%) | 11 (40.7%) | 0.701 |
 Female | 18 (64.3%) | 16 (59.3%) | |
Age (years) | 49.1 ± 11.2 | 50.6 ± 14.4 | 0.671 |
Height (cm) | 169.0 (160.3, 170.0) | 162.0 (158.0, 170.0) | 0.184 |
Weight (kg) | 62.9 ± 10.9 | 64.1 ± 11.3 | 0.682 |
BMI (kg·m−2) | 22.7 ± 2.9 | 23.7 ± 2.5 | 0.188 |
ASA class | |||
 I | 7 (25.0%) | 6 (22.2%) | 0.808 |
 II | 21 (75.0%) | 21 (77.8%) | |
Type of laparoscopic procedures | |||
 Hepatic hemangioma | 9 (32.1%) | 10 (37.0%) | 0.703 |
 Liver cancer | 19 (67.9%) | 17 (63.0%) | |
Surgery duration (min) | 165.5 ± 58.8 | 169.1 ± 60.2 | 0.819 |
Anesthesia time (min) | 213.1 ± 61.6 | 223.0 ± 64.3 | 0.563 |
Intraoperative parameters | |||
 Total remifentanil (μg) | 1084.3 ± 413.5 | 1165.9 ± 442.5 | 0.482 |
 Total sufentanil (μg) | 37.1 ± 5.1 | 37.9 ± 5.7 | 0.576 |
 Dexmedetomidine (μg) | 60.0 (42.5, 65.0) | 60.0 (42.0, 66.0) | 0.694 |
Preoperative QoR- 15 score (0—150) | 140.4 ± 3.4 | 139.0 ± 2.9 | 0.096 |
Preoperative liver function | |||
 AST (U/L) | 24.0 (18.3, 27.8) | 21.0 (18.0, 26.0) | 0.336 |
 ALT (U/L) | 18.0 (11.3, 23.0) | 15.0 (10.0, 24.0) | 0.781 |